Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Summa Health System
ClinicalTrials.gov Identifier:
NCT00773669
First received: October 15, 2008
Last updated: May 30, 2013
Last verified: May 2013
  Purpose

The primary goal of this retrospective study is to evaluate the male breast cancer patient population at Summa Health System/Akron City Hospital over a period of 18 years and compare the findings to historical data.

The objectives are to:

  • identify risk factors.
  • evaluate stage and histology at the time of presentation.
  • document treatment modalities and outcomes.
  • analyze outcomes for comparison to historical data.

Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

Resource links provided by NLM:


Further study details as provided by Summa Health System:

Primary Outcome Measures:
  • Retrospective chart review to evaluate the male breast cancer patient population at Summa Health System/Akron City Hospital over a period of years and compare the findings to historical data. [ Time Frame: Chart review from 1995-2007 ] [ Designated as safety issue: No ]

Enrollment: 24
Study Start Date: October 2008
Study Completion Date: December 2012
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Males with breast cancer.

Criteria

Inclusion Criteria:

  • Male breast cancer patients diagnosed and/or treated at Summa Health System/Akron City Hospital from the reference year of 1995 through 2007.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00773669

Sponsors and Collaborators
Summa Health System
Investigators
Principal Investigator: Gary Williams, MD Summa Health System
  More Information

No publications provided

Responsible Party: Summa Health System
ClinicalTrials.gov Identifier: NCT00773669     History of Changes
Other Study ID Numbers: Male Breast Cancer
Study First Received: October 15, 2008
Last Updated: May 30, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Summa Health System:
male breast cancer
Male breast cancer patients diagnosed and/or
treated at Summa Health System/Akron City Hospital
from the reference year of 1995 through 2007.

Additional relevant MeSH terms:
Breast Neoplasms
Breast Neoplasms, Male
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on August 21, 2014